DOCUMENT D'INFORMATION ETABLI CONFORMEMENT À L'ANNEXE IX DU REGLEMENT (UE) 2017/1129 DU PARLEMENT EUROPEEN ET DU CONSEIL DU 14 JUIN 2017, TEL QUE MODIFIE

Strasbourg, France, 27 November 2025, 00:15 a.m. CET – Transgene (Euronext Paris: TNG) had requested the suspension of trading of its shares (ISIN: FR0005175080) on Euronext Paris as from Wednesday,...

This press release may not be distributed directly or indirectly in the United States, Canada, United Kingdom, Australia or Japan. Success of a fundraising consisting of a reserved offering to...